Simple skin prick may predict chemo allergies, study hopes
NCT ID NCT07613905
First seen Jun 01, 2026 · Last updated Jun 12, 2026 · Updated 2 times
Summary
This study looks at whether a skin test can help predict severe allergic reactions to the chemotherapy drug oxaliplatin. About 380 cancer patients will receive a tiny injection of the drug under the skin before their regular treatment. Researchers will track who develops a rash or other allergic symptoms and compare those results to blood tests. The goal is to find a safer way to identify patients at risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERSENSITIVITY REACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fujian Cancer Hospital
Fuzhou, Fujian, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.